LONDON, March 13, 2026 /PRNewswire/ -- a leading Italian innovator in medical imaging - ultrasound, dedicated magnetic resonance and medical IT, as a leading provider of advanced currently underway in London (13-16 March 2026).
its new and innovative technology dedicated to urology:
, Esaote (Booth N16) is showcasing a comprehensive , with a strong focus on confidence, efficiency and clinical excellence. is at , offering automatic analysis of prostate mpMRI volumes and identifying suspicious regions of interest, therefore assisting urologists on enhancing target guidance and decision making.
PAM Technology is fully integrated into Esaote's UroFusion software, said "Our UroFusion package is designed to provide focal guidance during prostate targeted biopsies. Thanks to A.I., urologists have a seamless workflow, with similar duration as a standard biopsy exam, while improving confidence and accuracy during their biopsy procedures."
TP Biopsy and MRI-US Fusion guided by internationally recognised specialists and offering attendees the opportunity to experience the latest advances on UroFusion.
presence at EAU 2026 – with marks a significant and highlights the Company's ongoing advanced image quality, intuitive interaction and seamless fusion workflows
is a leader in medical imaging (ultrasound, MRI and diagnostic process management software). At the end of 2025, the Group counts 1,300 employees, half of which are based in Italy. With facilities in Genoa and Florence and its own production and research units in Italy and the Netherlands, Esaote is present in over 100 countries worldwide.
Photo - Logo -
View original content: https://www.prnewswire.co.uk/news-releases/esaote-at-eau-2026-introducing-exclusive-pam-technology-to-advance-precision-in-urological-imaging-302712678.html